Mutations of myosin and actin can produce familial hypertrophic cardiomyopathy (FHC) or dilated cardiomyopathy (DCM), diseases of the sarcomere where the resulting hypertrophy or dilation is associated with high rates of mortality and morbidity. In this study we use genetically-altered mice that mimic some of the key point mutations found in FHC (myosin: R453C, G741R, R403Q;actin: E99K, A331P, A295S) and DCM (myosin: S532P, F764L;actin R312H, E361G). Isolated myofibrils and permeabilized muscle strips will be studied mechanically to provide a detailed functional characterization of mutant contractile proteins within the spatial constraints of the structured myofilament lattice. This will be the first use of cardiac myofibrils to study the mechano-chemical alterations produced by point mutations in myosin and actin. The results will be correlated with in vivo and in vitro whole heart ventricular function studies and single molecule mechanics. Our studies will characterize the mechano-energetic alterations in terms of force, velocity, power, work-absorbing and work-producing elements, and cross-bridge kinetic parameters as well as cross-bridge efficiency and economy. We will test the hypothesis that functional alterations resulting from the specific actin and myosin mutations can be segregated into distinct subsets representing those that lead to FHC and those that lead to DCM.
The aims are: 1) use our newly developed myofibrillar mechanical assay to assess the extent to which FHC and DCM mutations alter force, velocity, power, dynamic stiffness, and the calcium dependencies of these parameters, and 2) use the skinned strip preparation to assess the extent to which ancillary changes (disarray and fibrosis) contribute to alterations of force, velocity, power, and dynamic stiffness in the mutant lines. This study will address the question as to how mutations in the same molecule can result in such markedly different phenotypes. At a minimum, the phenotypic differences revealed by the various mechanical and biochemical measurements will allow us to assign functional relevance to the underlying structural alterations caused by each mutation. The results of this study will help in our understanding of FHC and DCM.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL059408-10
Application #
7743426
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
2008-12-01
Budget End
2009-11-30
Support Year
10
Fiscal Year
2009
Total Cost
$401,796
Indirect Cost
Name
University of Vermont & St Agric College
Department
Type
DUNS #
066811191
City
Burlington
State
VT
Country
United States
Zip Code
05405
Singh, Sonia R; Robbins, Jeffrey (2018) Desmin and Cardiac Disease: An Unfolding Story. Circ Res 122:1324-1326
Lin, Brian Leei; Li, Amy; Mun, Ji Young et al. (2018) Skeletal myosin binding protein-C isoforms regulate thin filament activity in a Ca2+-dependent manner. Sci Rep 8:2604
Kensler, Robert W; Craig, Roger; Moss, Richard L (2017) Phosphorylation of cardiac myosin binding protein C releases myosin heads from the surface of cardiac thick filaments. Proc Natl Acad Sci U S A 114:E1355-E1364
McLendon, Patrick M; Davis, Gregory; Gulick, James et al. (2017) An Unbiased High-Throughput Screen to Identify Novel Effectors That Impact on Cardiomyocyte Aggregate Levels. Circ Res 121:604-616
Bhuiyan, Md Shenuarin; McLendon, Patrick; James, Jeanne et al. (2016) In vivo definition of cardiac myosin-binding protein C's critical interactions with myosin. Pflugers Arch 468:1685-95
Gupta, Manish K; McLendon, Patrick M; Gulick, James et al. (2016) UBC9-Mediated Sumoylation Favorably Impacts Cardiac Function in Compromised Hearts. Circ Res 118:1894-905
Warshaw, David M (2016) HEART DISEASE. Throttling back the heart's molecular motor. Science 351:556-7
James, Jeanne; Robbins, Jeffrey (2016) Healing a Heart Through Genetic Intervention. Circ Res 118:920-2
Mun, Ji Young; Kensler, Robert W; Harris, Samantha P et al. (2016) The cMyBP-C HCM variant L348P enhances thin filament activation through an increased shift in tropomyosin position. J Mol Cell Cardiol 91:141-7
Previs, Michael J; Mun, Ji Young; Michalek, Arthur J et al. (2016) Phosphorylation and calcium antagonistically tune myosin-binding protein C's structure and function. Proc Natl Acad Sci U S A 113:3239-44

Showing the most recent 10 out of 168 publications